Page last updated: 2024-11-01

nevirapine and Thyroid Cancer, Anaplastic

nevirapine has been researched along with Thyroid Cancer, Anaplastic in 2 studies

Nevirapine: A potent, non-nucleoside reverse transcriptase inhibitor used in combination with nucleoside analogues for treatment of HIV INFECTIONS and AIDS.
nevirapine : A dipyridodiazepine that is 5,11-dihydro-6H-dipyrido[3,2-b:2',3'-e][1,4]diazepine which is substituted by methyl, oxo, and cyclopropyl groups at positions 4, 6, and 11, respectively. A non-nucleoside reverse transcriptase inhibitor with activity against HIV-1, it is used in combination with other antiretrovirals for the treatment of HIV infection.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Dong, JJ2
Zhou, Y2
Liu, YT1
Zhang, ZW2
Zhou, XJ1
Wang, HJ2
Liao, L2

Other Studies

2 other studies available for nevirapine and Thyroid Cancer, Anaplastic

ArticleYear
In vitro evaluation of the therapeutic potential of nevirapine in treatment of human thyroid anaplastic carcinoma.
    Molecular and cellular endocrinology, 2013, May-06, Volume: 370, Issue:1-2

    Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Humans; Iodine Radioisotopes

2013
[Influences of nevirapine on cell proliferation and expression of sodium/iodide symporter in human anaplastic thyroid carcinoma cell line].
    Zhonghua yi xue za zhi, 2012, Mar-27, Volume: 92, Issue:12

    Topics: Cell Line, Tumor; Cell Proliferation; Humans; Nevirapine; Receptors, Thyrotropin; Symporters; Thyroi

2012